Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 31 - 60 of 334
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
		European Medicines Agency's website: Dacogen - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Dafiro - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Dafiro HCT - EMA: EPAR PI Finnish Swedish
PL	Resepti	Dailiport 0,5 mg, 1 mg, 2 mg, 3 mg, 5 mg depotkapseli, kova SPC 2023-11-20
PL	Resepti	Daisynelle 150 mikrog -20 mikrog ja 150 mikrog-30 mikrog tabletti SPC 2022-10-12
PL	Resepti	Daivobet 50-500 mikrog-g geeli SPC 2021-12-27
PL	Resepti	Daivobet 50-500 mikrog-g voide SPC 2024-09-01
		European Medicines Agency's website: Daklinza - EMA: EPAR PI Finnish Swedish
PL	Itsehoito	Daktacort emulsiovoide SPC 2024-01-10
PL	Itsehoito	Daktarin 2 prosenttia puuteri SPC 2022-10-03
PL	Itsehoito	Daktarin 2 prosenttinen emulsiovoide SPC 2024-01-10
PL	Resepti	Dalacin 10 mg-ml emulsio iholle SPC 2021-08-25
PL	Resepti	Dalacin 100mg emätinpuikko SPC 2021-07-01
PL	Resepti	DALACIN 15 mg-ml rakeet oraaliliuosta varten SPC 2021-12-22
PL	Resepti	Dalacin 150 mg, 300 mg kapseli SPC 2024-09-19
PL	Resepti	Dalacin 2 prosenttinen emätinemulsiovoide, SPC 2024-06-07
PL	Resepti	Dalbavancin Baxter 500 mg kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos SPC 2024-06-19
PL	Resepti	Dapagliflozin Krka 5 mg, 10 mg tabletti, kalvopäällysteinen SPC 2024-01-15
		European Medicines Agency's website: Dapagliflozin Viatris - EMA: EPAR PI Finnish Swedish
PL	Resepti	Daptomycin Accord Healthcare 350 mg, 500 mg injektio-infuusiokuiva-aine liuosta varten SPC 2023-11-09
PL	Resepti	Daptomycin Accordpharma 350 mg, 500 mg injektio-infuusiokuiva-aine, liuosta varten SPC 2019-11-21
PL	Resepti	Daptomycin BE Pharma 350 mg, 500 mg injektio-infuusiokuiva-aine, liuosta varten SPC 2022-11-18
PL	Resepti	Daptomycin hameln 350 mg, 500 mg injektio- infuusiokuiva-aine liuosta varten SPC 2024-03-01
		European Medicines Agency's website: Daptomycin Hospira - EMA: EPAR PI Finnish Swedish
PL	Resepti	Daptomycin Norameda 350 mg, 500 mg injektio-infuusiokuiva-aine liuosta varten SPC 2024-06-21
PL	Resepti	Daptomycin Norameda 500 mg injektio-infuusiokuiva-aine liuosta varten SPC 2022-06-06
PL	Resepti	Daptomycin Reddy 350 mg, 500 mg injektio-infuusiokuiva-aine liuosta varten SPC 2024-06-28
PL	Resepti	Darunavir Accord 400 mg, 800 mg tabletti, kalvopäällysteinen SPC 2024-07-12
PL	Resepti	Darunavir Accord 600 mg tabletti, kalvopäällysteinen SPC 2024-02-06
		European Medicines Agency's website: Darunavir Krka - EMA: EPAR PI Finnish Swedish
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  |  Next 30   >